Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-114 for Treatment of Full-Thickness Rotator Cuff Tear
KCT0003174Phase 3Completed
- Sponsor
- Tego Science
- Start
- Jul 2018
- Modality
- Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of TPX-114 in rotator cuff tear, sponsored by Tego Science. Started Jul 2018; status: completed.
02
Drugs
TPX-114
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on KCT0003174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003174.